Data are not limited to animal models—human positron emission tomography (PET) studies have also observed a decrease in CB1R availability in premanifest HD and a further progressive decrease in disease burden (Laere et al., 2010; Ceccarini et al., 2016). This evidence concerns the gene CNR1 and Huntington disease.